<DOC>
	<DOCNO>NCT00572767</DOCNO>
	<brief_summary>The aim study evaluate effect Dextro-amphetamin add physiotherapy motor recovery patient stroke . The study double-blinded placebo-controlled randomise control trial . Patients first-ever ischemic stroke receive Dexamphetamine ( 10mg ) twice per week duration five week baseline phase two week . The outcome measure focus motor recovery assess : - one two week study intervention ( baseline phase ) - five time study intervention - one week study intervention ( follow-up ) - six twelve month start study intervention ( follow-up ) .</brief_summary>
	<brief_title>Evaluation Effect Dextro-Amphetamin Added Physiotherapy Patients After Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<criteria>patient firstever ischemic stroke clinical relevant paresis upper low limb ( general clinical muscle test level four ) correlation clinical symptom brain imaging ( CT MRI ) able communicate neurological examiner understand aim/matter study ( without aphasia ) start first oral application study drug fourteenth 60th day stroke onset old 13 year give write informed consent ( two independent witness ) intracranial ( chronic ) subdural hemorrhage additional neurological psychiatric illness instable arrythmia control treated arterial hypertension ensure cardioembolic event anxiolytica , neuroleptica , alphaadrenergic antagonist agonist respectively certain anticonvulsiva antihypertonica manifest hyperthyreosis dementia terminal illness epilepsy , phaeochromocytoma glaucoma woman know pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>randomised-controlled trial</keyword>
	<keyword>ischemic stroke</keyword>
	<keyword>motor recovery</keyword>
	<keyword>amphetamine</keyword>
	<keyword>motor recovery patient first-ever ischemic stroke</keyword>
</DOC>